Cara Therapeutics, Inc. (CARA)

Apr 16, 2025 - CARA was delisted (reason: merged into TVRD)

15.96

-0.69 (-4.14%)

Inactive · Last trade price on Apr 15, 2025

Cara Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-70.87	-118.51	-85.47	-88.44	8.41
Depreciation & Amortization	0.19	0.26	0.25	1.55	1.02
Loss (Gain) From Sale of Assets	-	-	-	-0.07	-
Asset Writedown & Restructuring Costs	4.27	-	-	-	-
Loss (Gain) From Sale of Investments	-0.54	-0.4	0.26	0.82	-0.12
Stock-Based Compensation	8.93	13.73	17.73	20.79	14.84
Other Operating Activities	12.2	2.68	1.42	-	-22.26
Change in Accounts Receivable	2.36	0.5	-3.26	-	-
Change in Inventory	-1.04	-0.44	0.2	-2.58	-
Change in Accounts Payable	-21.44	3.28	5.68	-1.02	-2.78
Change in Income Taxes	0.7	-	-	0.81	-0.69
Change in Other Net Operating Assets	4.32	6.84	-15.54	8.06	-3.89
Operating Cash Flow	-60.92	-92.08	-78.73	-60.09	-5.49
Operating Cash Flow Growth	-	-	-	-	-

Investing Activities

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Capital Expenditures	-1.05	-2.38	-0.04	-0.04	-0.35
Sale of Property, Plant & Equipment	-	-	-	0.07	-
Investment in Securities	49.79	45.84	128.75	-4.78	-19.93
Investing Cash Flow	48.74	43.46	128.71	-4.75	-20.28

Financing Activities

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Issuance of Common Stock	-	1.68	0.31	46.61	39.14
Other Financing Activities	-3.6	36.47	-	-	-
Financing Cash Flow	-3.6	38.15	0.31	46.61	39.14

Net Cash Flow

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Cash Flow	-15.78	-10.47	50.29	-18.23	13.38

Free Cash Flow

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Free Cash Flow	-61.96	-94.45	-78.77	-60.13	-5.84
Free Cash Flow Growth	-	-	-	-	-
Free Cash Flow Margin	-868.19%	-450.46%	-188.15%	-261.10%	-4.32%
Free Cash Flow Per Share	-40.74	-62.80	-52.85	-42.68	-4.38
Levered Free Cash Flow	-44.23	-52.53	-48.35	-26.51	-9.67
Unlevered Free Cash Flow	-38.93	-52.16	-48.35	-26.51	-9.67

SEC Filings: 10-K · 10-Q